Review
Published on 02 Sep 2022
Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.968226
- 25,106 views
- 33 citations
Type at least 3 characters
604 articles
Articles
Original Research
Published on 02 Sep 2022
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.958136
- 4,635 views
- 11 citations
Original Research
Published on 02 Sep 2022
Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.930614
- 9,730 views
- 21 citations
Original Research
Published on 31 Aug 2022
Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.946165
- 2,918 views
- 5 citations
Original Research
Published on 29 Aug 2022
The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.918385
- 4,993 views
- 8 citations
Review
Published on 29 Aug 2022
Roxadustat: Not just for anemia
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.971795
- 35,243 views
- 33 citations
Original Research
Published on 29 Aug 2022
The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.919967
- 4,219 views
- 11 citations
Review
Published on 26 Aug 2022
The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.974361
- 5,486 views
- 12 citations
Original Research
Published on 26 Aug 2022
Inhibition of the IRE1/JNK pathway in renal tubular epithelial cells attenuates ferroptosis in acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.927641
- 5,318 views
- 23 citations
Review
Published on 25 Aug 2022
The critical role of dysregulated autophagy in the progression of diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.977410
- 3,723 views
- 8 citations
Review
Published on 24 Aug 2022
Autophagy in renal fibrosis: Protection or promotion?
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.963920
- 3,771 views
- 10 citations
Original Research
Published on 23 Aug 2022
Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935937
- 6,583 views
- 14 citations
Original Research
Published on 22 Aug 2022
Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.931282
- 4,503 views
- 5 citations
Original Research
Published on 19 Aug 2022
Using network pharmacology to explore the mechanism of Danggui-Shaoyao-San in the treatment of diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.832299
- 4,411 views
- 4 citations
Original Research
Published on 17 Aug 2022
Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.964370
- 4,263 views
- 26 citations
Original Research
Published on 17 Aug 2022
Exploring the pathogenesis of diabetic kidney disease by microarray data analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.932205
- 5,746 views
- 9 citations